This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DBF4 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DBF4 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~76.9 kDa | |
| Observed band | ~80 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-induced mobility shift | |
| Regulation | G2m checkpoint | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for DBF4 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human HepG2 , Lane 2: human SH-SY5Y , Lane 3: rat PC-12 , Lane 4: mouse NIH/3T3 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-DBF4 antigen affinity purified polyclonal antibody (Catalog # A01348-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for DBF4 at approximately 80 kDa. The expected band size for DBF4 is at 80 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 80 kDa |
DBF4 has a 76.9 kDa predicted backbone but runs near 80 kDa on blots due to extensive phosphorylation, with alternative splicing yielding two isoforms.
| single band around 80 kDa | matches the empirically observed DBF4 band, slightly above its 76.9 kDa predicted mass |
| band running above the 76.9 kDa predicted mass | reflects DBF4's extensive phosphorylation (12 annotated phosphosites), which retards SDS-PAGE mobility |
| doublet or two closely spaced bands | corresponds to the two annotated splice isoforms (1 and 2) of DBF4 |
| sharp band without smearing | DBF4 has no glycosylation sites, so no glyco-driven heterogeneity is expected |
| band unchanged between reducing and non-reducing conditions | DBF4 has no annotated disulfide bonds, so it does not form covalent dimers |
| weak or absent band in cytoplasmic-only fractions | DBF4 is a nuclear protein, so nuclear or whole-cell lysis is needed to detect it |
| predicted mass (76.9 kDa, 674 aa) | sets the baseline migration position for full-length, unmodified DBF4 |
| multiple phosphorylation sites (e.g. Thr273, Ser312, Thr345, Ser508) | extensive phosphorylation shifts the apparent band upward, consistent with the ~80 kDa observed band |
| alternative splicing (isoforms 1 and 2) | can produce an additional band of differing size alongside the canonical isoform |
| nuclear subcellular localization | requires nuclear or whole-cell lysis; cytoplasmic-only fractions may show little or no band |
| absence of glycosylation and disulfide bonds | band should stay sharp and unaffected by reducing versus non-reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | DBF4 is nuclear and can be depleted from cytoplasmic-only or poorly extracted fractions | use a whole-cell or nuclear extraction lysis buffer and confirm recovery with a nuclear marker |
| Band higher than expected | extensive phosphorylation at the annotated Ser/Thr sites shifts DBF4 above its 76.9 kDa predicted mass | treat lysate with lambda phosphatase and compare migration to confirm the phospho-driven shift |
| Multiple bands | co-detection of splice isoforms 1 and 2 by an antibody recognizing a shared region | check the immunogen location against both isoform sequences to determine which isoform(s) are detected |
| Weak or no signal | DBF4 expression is cell-cycle regulated and can be low outside S phase | use synchronized or S-phase-enriched cultures and increase total protein loaded |
| Fragments below expected size | DBF4 is turned over by cell-cycle-linked degradation, producing proteolytic fragments if protease activity is not controlled | add fresh protease and phosphatase inhibitors during lysis and keep samples cold throughout preparation |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for DBF4, answered from its protein features.
BosterBio's DBF4 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
The recommended anti-DBF4 antibody below is a best-performing, well-cited reagent for Western blot, thoroughly validated and orthogonally cross-checked against negative-control tissue and complementary detection methods to ensure specific, reproducible band detection.
Which to pick: Only one Boster antibody, A01348-2, is catalogued for DBF4, so it is the default choice; it includes an actual Western blot validation image confirming specific band detection.